Spinal Structure and Mobility in Chronic Obstructive Pulmonary Disease

NCT05021068 | Completed

• 1 other identifier: IKC1233
• Study Type: observational
• Target: 98
• Locations: 1 country
• Sites: 1

Brief Summary

In recent studies with musculoskeletal system disorders in chronic respiratory patients, it has been reported that postural control is affected in COPD patients. The aim of this study to investigate relationship between spinal structure and mobility an severity of dyspnea in patients with COPD.

Conditions

COPD; Postural; Defect; Respiratory Function Impaired; Dyspnea

Keywords

copd; posture; respiratory function; dyspnea

Outcome Measures

Primary Outcomes (1)

• Spinal Structure and Mobility

  Spinal mouse measurement

  15 minutes (single application)

Secondary Outcomes (2)

• Pulmonary Functions

  10 minutes (single application)

• Dyspnea Severity

  5 minutes (single application)

Study Arms (2)

COPD Patients

The respiratory functions of the participants will be measured in accordance with the ATS-ERS criteria. After measurement; forced expiratory volume in one second (FEV1), forced vital capacity (FVC), FEV1/FVC, total lung capacity (TLC), residual volume (RV), inspiratory capacity (IC), vital capacity (VC) parameters will be recorded. Spinal structure and mobility will be evaluated with the Spinal Mouse device in the sagittal and frontal planes in standing and sitting positions. For the sagittal plane, the measurements were first in the neutral, then in the maximum flexion and extension positions, for the frontal plane; neutral, right and left lateral flexions will be performed. Patients will be asked to mark the level of activity that causes dyspnea on the Medical Council Research Scale (MMRC) Dyspnea Score.

Other: Postural Assessment

Control Group

The respiratory functions of the participants will be measured in accordance with the ATS-ERS criteria. After measurement; forced expiratory volume in one second (FEV1), forced vital capacity (FVC), FEV1/FVC, total lung capacity (TLC), residual volume (RV), inspiratory capacity (IC), vital capacity (VC) parameters will be recorded. Spinal structure and mobility will be evaluated with the Spinal Mouse device in the sagittal and frontal planes in standing and sitting positions. For the sagittal plane, the measurements were first in the neutral, then in the maximum flexion and extension positions, for the frontal plane; neutral, right and left lateral flexions will be performed. Patients will be asked to mark the level of activity that causes dyspnea on the Medical Council Research Scale (MMRC) Dyspnea Score.

Other: Postural Assessment

Interventions

Postural Assessment OTHER

Spinal mouse measurement

Also known as: Respiratory Function Test, MMRC Dyspnea measurement

COPD Patients; Control Group

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

COPD patients over 18 years old

You may qualify if:

• Volunteer to participate in the study
• Be over 18 years old
• Being clinically stable
• Not having a COPD attack in the last 3 months at least

You may not qualify if:

• Refusing to participate in the research
• Having had spinal surgery Presence of back and shoulder pain
• Idiopathic scoliosis
• Ankylosing spondylitis
• Presence of respiratory disease other than COPD
• Difficulty understanding verbal commands

Sponsors & Collaborators

• Izmir Katip Celebi University: lead

Study Sites (1)

Dr. Suat Seren Chest Diseases and Surgery Training and Research Hospital

Izmir, 35620, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Pulmonary Disease, Chronic Obstructive; Respiratory Insufficiency; Dyspnea; Respiratory Aspiration

Interventions

Respiratory Physiological Phenomena

Condition Hierarchy (Ancestors)

Lung Diseases, Obstructive; Lung Diseases; Respiratory Tract Diseases; Chronic Disease; Disease Attributes; Pathologic Processes; Pathological Conditions, Signs and Symptoms; Respiration Disorders; Signs and Symptoms, Respiratory; Signs and Symptoms

Intervention Hierarchy (Ancestors)

Circulatory and Respiratory Physiological Phenomena

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: CROSS SECTIONAL
• Target Duration: 1 Day
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Assoc. Prof

Study Record Dates

• First Submitted: August 19, 2021
• First Posted: August 25, 2021
• Study Start: March 1, 2018
• Primary Completion: March 1, 2021
• Study Completion: March 1, 2021
• Last Updated: August 30, 2021

Record last verified: 2021-08

Data Sharing

• IPD Sharing: Will not share

Locations

TU (1)